Skip to main content

Table 2 Time Course of Parameters after BAV in the MR Group

From: Mid-term effect of balloon aortic valvuloplasty on mitral regurgitation in aortic stenosis

 Baseline1 month after BAVP value3 months after BAVP value
Clinical data
 NYHA III/IV, n (%)28 (70.0)1 (2.5)< 0.0011 (2.5)< 0.001
Laboratory data
 BNP, pg/mL702 (391–1042)421 (206–618)0.002281 (182–401)< 0.001
Conventional echo parameters
 LVEDD, mm46.2 ± 6.045.4 ± 6.50.23744.0 ± 6.80.033
 LVESD, mm32.6 ± 6.831.2 ± 7.70.14828.6 ± 7.0< 0.001
 LVEF, %51.4 ± 13.054.1 ± 10.10.08957.4 ± 12.50.007
 LVSVI, mL38.3 ± 11.741.3 ± 11.10.05244.6 ± 11.20.002
 E/A1.0 (0.6–1.6)0.7 (0.6–1.0)0.0030.7 (0.5–0.9)0.001
 E/e’20.5 ± 8.715.5 ± 6.2< 0.00116.1 ± 7bnp.10.002
 TR-PG, mmHg40.5 ± 15.429.7 ± 8.4< 0.00128.9 ± 6.4< 0.001
 AR ≥ moderate, n (%)5 (12.5)6 (15.0)1.0004 (10.0)1.000
AS parameters
 AVA, cm20.66 ± 0.170.84 ± 0.19< 0.0010.80 ± 0.200.001
 AVAi, cm2/m20.47 ± 0.120.59 ± 0.12< 0.0010.57 ± 0.12< 0.001
 Peak V, m/s61.0 ± 27.145.0 ± 19.1< 0.00151.7 ± 25.10.002
 mPG (mmHg)35.6 ± 17.024.9 ± 11.5< 0.00129.8 ± 15.20.003
MR parameters
 MR jet area, cm26.3 (4.5–9.7)3.5 (1.5–7.4)< 0.0012.1 (1.1–6.0)< 0.001
 %MR, %33.3 (22.6–42.7)16.0 (8.9–34.3)< 0.00112.0 (4.7–29.4)< 0.001
 Mitral annular dimension, mm28.5 ± 4.927.2 ± 4.20.03025.5 ± 3.3< 0.001
 Tenting height, mm4.1 ± 1.93.8 ± 1.90.3072.8 ± 1.1< 0.001
 Tenting area, mm258.8 ± 31.652.0 ± 28.50.16935.5 ± 14.5< 0.001